|Outsourcing Outlook Eric LangerCMOs Continue to Improve Overall Biomanufacturing Performance|
|Regulatory Watch Jill Wechsler FDA Overhauls Inspection Operations|
|EU Regulatory Watch Sean Milmo EU's New Telematics Strategy for the Regulation of Medicines|
New instrumentation at the SGS Mississauga, Canada facility advances testing capabilities for packaging and container testing.
Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.